Ryota Usui

Head

Kure Kyosai Hospital

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ryota Usui is the Head at Kansai Electric Power Hospital in Japan. His research encompasses various aspects of diabetes treatment, particularly focusing on insulin sensitization and incretin-based therapies. Recently, he has contributed to studies examining the effects of tirzepatide, imeglimin, and glucagon-like peptide-1 receptor agonists on metabolic functions in individuals with type 2 diabetes. His work also includes innovative animal models aimed at understanding pancreatic beta-cell dynamics.

Articles (9)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Kenta MUROTANI

Kurume University

JAPAN

View details

Hisato Tatsuoka

Visiting Associate Professor

JAPAN

View details

Pedro Luis Herrera Merino

Full Professor

University of Geneva, Faculty of Medicine

SWITZERLAND

View details

shinsuke tokumoto

Kyoto University

JAPAN

View details

Nobuya Inagaki

Professor and Chairman

Kyoto Prefectural University of Medicine

JAPAN

View details

Takuya Haraguchi

Fujita Health University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ryota Usui

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Differential effects of imeglimin and metformin on insulin and incretin secretion—An exploratory randomized controlled trial

Early induction of insulin sensitisation treated by tirzepatide: a prospective, single-arm, open-label study in Japanese individuals with obesity and type 2 diabetes

Imeglimin and DPP‐4 inhibitors: A promising therapeutic strategy for type 2 diabetes individuals with reduced insulin secretion

Glucagon Stimulation Test and Insulin Secretory Capacity in Clinical Assessment of Incretin-Based Therapy for Diabetes

Effects of glucagon‐like peptide‐1 receptor agonists on secretions of insulin and glucagon and gastric emptying in Japanese individuals with type 2 diabetes: A prospective, observational study

Carbonic anhydrase 8 (CAR8) negatively regulates GLP-1 secretion from enteroendocrine cells in response to long-chain fatty acids

Generation and Characterization of a Novel Mouse Model that Allows Spatiotemporal Quantification of Pancreatic β-Cell Proliferation.

Single-Cell Transcriptome Analysis Dissects the Replicating Process of Pancreatic Beta Cells in Partial Pancreatectomy Model.

Acromegaly accompanied by diabetes mellitus and polycystic kidney disease.

Collaborators (6)

Kenta MUROTANI

Hisato Tatsuoka

Pedro Luis Herrera Merino

shinsuke tokumoto

Nobuya Inagaki

Takuya Haraguchi

Make your next move.